Showing items 1906-1955 of 2489 (50 Page(s) Totally)
<< < 34 35 36 37 38 39 40 41 42 43 > >>
View [10|25|50] records per page
| 臺大學術典藏 |
2020-11-02T02:04:54Z |
The relationship between visceral adiposity and the risk of erosive esophagitis in severely obese Chinese patients
|
Wang W.-M.; MING-SHIANG WU; Lin J.-T.; Lee C.-T.; Wu M.-T.; Chang C.-Y.; Huang C.-K.; Tu H.-P.; Lee Y.-C.; Tai C.-M. |
| 臺大學術典藏 |
2020-11-02T02:04:54Z |
Author's response
|
MING-SHIANG WU; Lee Y.-C.; Chen M.-J.; Chang C.-Y.; Lin J.-T.; Liou J.-M. |
| 臺大學術典藏 |
2020-11-02T02:04:53Z |
Prospective survey for the etiology and outcome of peptic ulcer bleeding: A community based study in Southern Taiwan
|
Chang C.-Y.; MING-SHIANG WU; Lee C.-T.; Hwang J.-C.; Tai C.-M.; Perng D.-S.; Lin C.-W.; Wang W.-L.; Wang J.-D.; Lin J.-T. |
| 臺大學術典藏 |
2020-11-02T02:04:53Z |
Genotypic resistance in Helicobacter pylori strains correlates with susceptibility test and treatment outcomes after levofloxacinand clarithromycin-based therapies
|
Lin J.-T.; Liou J.-M.; Chang C.-Y.; Sheng W.-H.; Wang Y.-C.; Chen M.-J.; Lee Y.-C.; Hung H.-W.; Chian H.; Chang S.-C.; MING-SHIANG WU |
| 臺大學術典藏 |
2020-11-02T02:04:52Z |
Empirical modified sequential therapy containing levofloxacin and high-dose esomeprazole in second-line therapy for Helicobacter pylori infection: A multicentre clinical trial
|
Liou J.-M.; Chen C.-C.; Chen M.-J.; Chang C.-Y.; Fang Y.-J.; Lee J.-Y.; Sheng W.-H.; Wang H.-P.; MING-SHIANG WU; Lin J.-T. |
| 臺大學術典藏 |
2020-11-02T02:04:51Z |
Revisit of field cancerization in squamous cell carcinoma of upper aerodigestive tract: Better risk assessment with epigenetic markers
|
Wang C.-P.; Ko J.-Y.; Lee J.-M.; Chiu H.-M.; Lin J.-T.; Yamashita S.; Oka D.; Watanabe N.; Matsuda Y.; Ushijima T.; MING-SHIANG WU; Wang H.-P.; Lee Y.-C. |
| 臺大學術典藏 |
2020-11-02T02:04:51Z |
Mutations in BRAF correlate with poor survival of colorectal cancers in Chinese population
|
Liang J.-T.; Lin J.-T.; Wang H.-P.; Chen C.-C.; Chen M.-J.; Chiu H.-M.; Liou J.-M.; MING-SHIANG WU; Shun C.-T. |
| 臺大學術典藏 |
2020-11-02T02:04:50Z |
Glycated hemoglobin A1c is superior to fasting plasma glucose as an independent risk factor for colorectal neoplasia
|
MING-SHIANG WU; Liu H.-H.; Lin J.-T.; Chang C.-C.; Liou J.-M.; Hsu Y.-C.; Chiu H.-M. |
| 臺大學術典藏 |
2020-11-02T02:04:50Z |
Different bowel preparation schedule leads to different diagnostic yield of proximal and nonpolypoid colorectal neoplasm at screening colonoscopy in average-risk population
|
Chiu H.-M.; Lin J.-T.; Lee Y.-C.; Liang J.-T.; Shun C.-T.; Wang H.-P.; MING-SHIANG WU |
| 臺大學術典藏 |
2020-11-02T02:04:49Z |
Randomised clinical trial: High-dose vs. standard-dose proton pump inhibitors for the prevention of recurrent haemorrhage after combined endoscopic haemostasis of bleeding peptic ulcers
|
Chen C.-C.; Lee J.-Y.; Fang Y.-J.; Hsu S.-J.; Han M.-L.; Tseng P.-H.; Liou J.-M.; Hu F.-C.; Lin T.-L.; MING-SHIANG WU; Wang H.-P.; Lin J.-T. |
| 臺大學術典藏 |
2020-11-02T02:04:49Z |
Can clinical features stratify use of endoscopy for dyspeptic patients with high background prevalence of upper gastrointestinal cancer?
|
MING-SHIANG WU; Wang H.-P.; Lin J.-T.; Wu H.-T.; Lin H.-J.; Hsu W.-L.; Yang T.-H.; Liou J.-M.; Hsu Y.-C. |
| 臺大學術典藏 |
2020-11-02T02:04:48Z |
CXCR4 expression predicts early liver recurrence and poor survival after resection of pancreatic adenocarcinoma
|
Liao W.-C.; Wang H.-P.; Huang H.-Y.; MING-SHIANG WU; Chiang H.; Tien Y.-W.; Lin Y.-L.; Lin J.-T. |
| 臺大學術典藏 |
2020-11-02T02:04:48Z |
Long-term risk of recurrent peptic ulcer bleeding in patients with liver cirrhosis: A 10-year nationwide cohort study
|
Hsu Y.-C.; Lin J.-T.; Chen T.-T.; MING-SHIANG WU; Wu C.-Y. |
| 臺大學術典藏 |
2020-11-02T02:04:47Z |
Sequential versus triple therapy for the first-line treatment of Helicobacter pylori: A multicentre, open-label, randomised trial
|
MING-SHIANG WU; Lee Y.-C.; Liou J.-M.; Chen C.-C.; Chen M.-J.; Chen C.-C.; Chang C.-Y.; Fang Y.-J.; Lee J.-Y.; Hsu S.-J.; Luo J.-C.; Chang W.-H.; Hsu Y.-C.; Tseng C.-H.; Tseng P.-H.; Wang H.-P.; Yang U.-C.; Shun C.-T.; Lin J.-T. |
| 臺大學術典藏 |
2020-11-02T02:04:47Z |
Association between nucleoside analogues and risk of hepatitis B virus-related hepatocellular carcinoma recurrence following liver resection
|
Wu C.-Y.; Chen Y.-J.; Ho H.J.; Hsu Y.-C.; Kuo K.N.; MING-SHIANG WU; Lin J.-T. |
| 臺大學術典藏 |
2020-11-02T02:04:46Z |
A nationwide population-based study shows increasing incidence of cholangiocarcinoma
|
Wu C.-Y.; Chen T.-T.; Ho H.J.; MING-SHIANG WU; Kuo K.N.; Lee T.-Y.; Lin J.-T. |
| 臺大學術典藏 |
2020-11-02T02:04:45Z |
The benefit of mass eradication of helicobacter pylori infection: A community-based study of gastric cancer prevention
|
Lee Y.-C.; Chen T.H.-H.; Chiu H.-M.; Shun C.-T.; Chiang H.; Liu T.-Y.; MING-SHIANG WU; Lin J.-T. |
| 臺大學術典藏 |
2020-11-02T02:04:45Z |
Efficacy of genotypic resistance-guided sequential therapy in the third-line treatment of refractory Helicobacter pylori infection: A multicentre clinical trial
|
Tai C.-M.; Wang Y.-C.; Wang C.-H.; Kuo S.-H.; Wu C.-Y.; Chang W.-H.; Wang H.-P.; Shun C.-T.; Wu J.-Y.; Lee Y.-C.; Lin J.-T.; MING-SHIANG WU; Lin C.-H.; Chow L.-P.; Cheng T.-Y.; Wu C.-Y.; Lee Ching-Tai C.-T, Wang W.-L.; Liou J.-M.; Chen C.-C.; Chang C.-Y.; Chen M.-J.; Fang Y.-J.; Lee J.-Y.; Chen C.-C.; Hsu S.-J.; Hsu Y.-C.; Tseng C.-H.; Tseng P.-H.; Chang L. |
| 臺大學術典藏 |
2020-11-02T02:04:44Z |
The benefit of pretreatment esophageal screening with image-enhanced endoscopy on the survival of patients with hypopharyngeal cancer
|
Wang W.-L.; Wang C.-P.; Wang H.-P.; Lee C.-T.; Chang C.-Y.; Tai C.-M.; Tseng C.-H.; Hwang T.-Z.; Wang C.-C.; Lin J.-T.; Lee Y.-C.; MING-SHIANG WU; Lou P.-J.; Ko J.-Y.; Lee J.-M.; Chiu H.-M.; Tseng P.-H.; Lo J.-L. |
| 臺大學術典藏 |
2020-11-02T02:04:43Z |
Adjuvant treatments for resected pancreatic adenocarcinoma: A systematic review and network meta-analysis
|
Liao W.-C.; Chien K.-L.; Lin Y.-L.; MING-SHIANG WU; Lin J.-T.; Wang H.-P.; Tu Y.-K. |
| 臺大學術典藏 |
2020-11-02T02:04:43Z |
Hepatic resection for hepatocellular carcinoma patients on hemodialysis for Uremia: A nationwide cohort study
|
Wu C.-Y.; Liu Y.-Y.; Kuo K.N.; Yeh C.-C.; Lin J.-T.; Jeng L.-B.; Charalampos I.; Chen T.-T.; Lee T.-Y.; MING-SHIANG WU |
| 臺大學術典藏 |
2020-11-02T02:04:42Z |
Genetic polymorphisms and tissue expression of interleukin-22 associated with risk and therapeutic response of gastric mucosa-associated lymphoid tissue lymphoma
|
Liao F.; Hsu Y.-C.; Kuo S.-H.; Yang Y.-C.; Chen J.-P.; Hsu P.-N.; Lin C.-W.; Chen L.-T.; Cheng A.-L.; Fann C.S.J.; Lin J.-T.; MING-SHIANG WU |
| 臺大學術典藏 |
2020-11-02T02:04:41Z |
Antiviral treatment for hepatitis C virus infection is associated with improved renal and cardiovascular outcomes in diabetic patients
|
Liu Y.-Y.; Wu C.-Y.; Hsiao N.-W.; MING-SHIANG WU; Huang Y.-T.; Kao Y.-H.; Ho H.J.; Lin J.-T.; Hsu Y.-C. |
| 臺大學術典藏 |
2020-11-02T02:04:41Z |
Normal values and symptom correlation of a simplified oatmeal-based gastric emptying study in the Chinese population
|
Tseng P.-H.; Wu Y.-W.; Lee Y.-C.; Cheng M.-F.; Tzen K.-Y.; Wang H.-P.; Lin J.-T.; Hsieh S.-T.; Yang W.-S.; MING-SHIANG WU |
| 臺大學術典藏 |
2020-11-02T02:04:40Z |
Formyl peptide receptor 1 expression is associated with tumor progression and survival in gastric cancer
|
Cheng T.-Y.; MING-SHIANG WU; Lin J.-T.; Lin M.-T.; Shun C.-T.; Hua K.-T.; Kuo M.-L. |
| 臺大學術典藏 |
2020-11-02T02:04:40Z |
Mutational profiles of different macroscopic subtypes of colorectal adenoma reveal distinct pathogenetic roles for KRAS, BRAF and PIK3CA
|
MING-SHIANG WU; Lee Y.-C.; Chen C.-C.; Lin J.-T.; Liang J.-T.; Shun C.-T.; Chiu H.-M.; Chang L.-C. |
| 臺大學術典藏 |
2020-11-02T02:04:38Z |
Association of esophageal inflammation, obesity and gastroesophageal reflux disease: From FDG PET/CT perspective
|
Yang W.-S.; MING-SHIANG WU; Lin J.-T.; Wang H.-P.; Tu C.-H.; Chiu H.-M.; Wang S.-Y.; Lee Y.-C.; Wu Y.-W.; Tseng P.-H. |
| 臺大學術典藏 |
2020-11-02T02:04:35Z |
Comparative in vitro antimicrobial susceptibility and synergistic activity of antimicrobial combinations against Helicobacter pylori isolates in Taiwan
|
Sheng W.-H.; Liou J.-M.; Wang H.-P.; MING-SHIANG WU; Lin J.-T.; Chang S.-C.; Cheng A. |
| 臺大學術典藏 |
2020-11-02T02:04:34Z |
Blood glucose concentration and risk of pancreatic cancer: Systematic review and dose-response meta-analysis
|
Chien K.-L.; Wang H.-P.; Lin J.-T.; Liao W.-C.; Tu Y.-K.; MING-SHIANG WU |
| 臺大學術典藏 |
2020-11-02T02:04:34Z |
Evaluation of the effect of cumulative operator experience on hepatocellular carcinoma recurrence after primary treatment with radiofrequency ablation
|
Lee T.-Y.; Lin J.-T.; Ho H.J.; MING-SHIANG WU; Wu C.-Y. |
| 臺大學術典藏 |
2020-11-02T02:04:33Z |
The primary resistance of Helicobacter pylori in Taiwan after the national policy to restrict antibiotic consumption and its relation to virulence factors - A nationwide study
|
Lee Y.-C.; Wang W.-L.; Lee C.-T.; Tai C.-M.; MING-SHIANG WU; Bair M.-J.; Lin J.-T.; Sheu B.-S.; Wang H.-P.; Chang C.-C.; Yang T.-H.; Wu C.-Y.; Liou J.-M.; Chang C.-Y.; Chen M.-J.; Chen C.-C.; Fang Y.-J.; Lee J.-Y.; Wu J.-Y.; Luo J.-C.; Liou T.-C.; Chang W.-H.; Tseng C.-H.; Helicobacter Consortium; Taiwan Gastrointestinal Disease; Wang Y.-C. |
| 臺大學術典藏 |
2020-11-02T02:04:32Z |
Consensus of gastroesophageal reflux disease in Taiwan with endoscopy-based approach covered by National Health Insurance
|
Lin J.-T.; Sheu B.-S.; Chiu C.-T.; Lee Y.-C.; Chang C.-Y.; Wu D.-C.; Liou J.-M.; MING-SHIANG WU; Chang W.-L.; Wu C.-Y. |
| 臺大學術典藏 |
2020-11-02T02:04:29Z |
Systematic review with meta-analysis: 10- or 14-day sequential therapy vs. 14-day triple therapy in the first line treatment of Helicobacter pylori infection
|
Chen M.-J.; Liou J.-M.; Chen C.-C.; Lee Y.-C.; Chang C.-Y.; Wu J.-Y.; Bair M.-J.; Lin J.-T.; MING-SHIANG WU |
| 臺大學術典藏 |
2020-11-02T02:04:29Z |
Prevention of gastric cancer by helicobacter pylori eradication: Current evidence and future prospects
|
Liou J.-M.; Lin J.-T.; MING-SHIANG WU |
| 臺大學術典藏 |
2020-11-02T02:04:27Z |
Association between nucleos(t)ide analog and tumor recurrence in hepatitis B virus-related hepatocellular carcinoma after radiofrequency ablation
|
Lee T.-Y.; Lin J.-T.; Zeng Y.-S.; Chen Y.-J.; MING-SHIANG WU; Wu C.-Y. |
| 臺大學術典藏 |
2020-11-02T02:04:26Z |
Sequential therapy for 10 days versus triple therapy for 14 days in the eradication of Helicobacter pylori in the community and hospital populations: A randomised trial
|
Helicobacter Consortium; Fang Y.-J.; Lee J.-Y.; Yang T.-H.; Luo J.-C.; Wu J.-Y.; Liou T.-C.; Chang W.-H.; Hsu Y.-C.; Tseng C.-H.; Chang C.-C.; Bair M.-J.; Liu T.-Y.; Hsieh C.-F.; Tsao F.-Y.; Shun C.-T.; Lin J.-T.; Lee Y.-C.; MING-SHIANG WU; the Taiwan Gastrointestinal Disease; Liou J.-M.; Chen C.-C.; Chang C.-Y.; Chen M.-J.; Chen C.-C. |
| 臺大學術典藏 |
2020-11-02T02:04:26Z |
Association Between Serum Level of Hepatitis B Surface Antigen at End of Entecavir Therapy and Risk of Relapse in E Antigen�VNegative Patients
|
Lin J.-T.; Wu C.-Y.; Hung H.-W.; Fang Y.-J.; Chen C.-C.; Chiang M.-F.; Wang C.-S.; Yang T.-H.; Wang W.-L.; Kao J.-H.; MING-SHIANG WU; Chang C.-Y.; Hsu Y.-C.; Mo L.-R. |
| 臺大學術典藏 |
2020-11-02T02:04:26Z |
Systematic review with meta-analysis: the efficacy of levofloxacin triple therapy as the first- or second-line treatments of Helicobacter pylori infection
|
Chen P.-Y.; MING-SHIANG WU; Chen C.-Y.; Bair M.-J.; Chou C.-K.; Lin J.-T.; Liou J.-M.; for the Taiwan Gastrointestinal Disease; Helicobacter Consortium |
| 臺大學術典藏 |
2020-11-02T02:04:25Z |
Concomitant, bismuth quadruple, and 14-day triple therapy in the first-line treatment of Helicobacter pylori: a multicentre, open-label, randomised trial
|
Chen C.-Y.; Chen P.-Y.; Shun C.-T.; Hsu W.-F.; Hu W.-H.; Chen Y.-N.; Sheu B.-S.; Lin J.-T.; Wu J.-Y.; El-Omar E.M.; MING-SHIANG WU; Taiwan Gastrointestinal Disease; Helicobacter Consortium; Chang C.-C.; Luo J.-C.; Yang T.-H.; Lee J.-Y.; Hsu Y.-C.; Chen C.-C.; Tseng C.-H.; Chen M.-J.; Lee Y.-C.; Chang C.-Y.; Bair M.-J.; Chen C.-C.; Fang Y.-J.; Liou J.-M. |
| 臺大學術典藏 |
2020-11-02T02:04:24Z |
Bismuth and Non-bismuth Quadruple Therapy for Helicobacter pylori Eradication: Time to Make?the?Switch in Clinical?Practice?
|
Liou J.-M.; Lin J.-T.; MING-SHIANG WU |
| 臺大學術典藏 |
2020-11-02T02:04:23Z |
Distinct Clinicopathological Features and Prognosis of Helicobacter pylori Negative Gastric Cancer
|
MING-SHIANG WU; Tsai K.-F.; Liou J.-M.; Chen M.-J.; Chen C.-C.; Kuo S.-H.; Lai I.-R.; Yeh K.-H.; Lin M.-T.; Wang H.-P.; Cheng A.-L.; Lin J.-T.; Shun C.-T. |
| 臺大學術典藏 |
2020-11-02T02:04:22Z |
Consensus on the clinical management, screening-to-treat, and surveillance of Helicobacter pylori infection to improve gastric cancer control on a nationwide scale
|
Wu D.-C.; Liou J.-M.; Wu C.-Y.; Cheng H.-C.; Lee Y.-C.; Hsu P.-I.; Chang C.-C.; Chang W.-L.; Lin J.-T.; Lo J.-C.; Chiu C.-T.; MING-SHIANG WU; Sheu B.-S. |
| 臺大學術典藏 |
2020-11-02T02:04:21Z |
Serum viral load at the virological relapse predicts subsequent clinical flares in chronic hepatitis B patients off entecavir therapy
|
Lin J.-T.; Wu C.-Y.; Lin C.-W.; Tai C.-M.; Chen C.-C.; Tseng C.-H.; Kao J.-H.; Yang T.-H.; MING-SHIANG WU; Chang C.-Y.; Mo L.-R.; Hsu Y.-C. |
| 臺大學術典藏 |
2020-11-02T02:04:20Z |
Impact of amoxicillin resistance on the efficacy of amoxicillincontaining regimens for Helicobacter pylori eradication: Analysis of five randomized trials
|
Chen M.-J.; MING-SHIANG WU; Chen C.-C.; Chen C.-C.; Fang Y.-J.; Bair M.-J.; Chang C.-Y.; Lee J.-Y.; Hsu W.-F.; Luo J.-C.; Lin J.-T.; Liou J.-M.; on behalf of the Taiwan Gastrointestinal Disease; Helicobacter Consortium |
| 臺大學術典藏 |
2020-11-02T02:04:20Z |
Primary antibiotic resistance in Helicobacter pylori in the Asia-Pacific region: a systematic review and meta-analysis
|
Microbiota; for the, Asian Pacific Alliance on Helicobacter; MING-SHIANG WU; Tu Y.-K.; Yamaoka Y.; Lin J.-T.; Lu H.; Das R.; Goh K.L.; Leow A.H.R.; Wu J.-Y.; El-Omar E.M.; Liou J.-M.; Kuo Y.-T. |
| 臺大學術典藏 |
2020-11-02T02:04:19Z |
Nutrition therapy in esophageal cancer�XConsensus statement of the Gastroenterological Society of Taiwan
|
Chu C.-H.; MING-SHIANG WU; Lin J.-T.; Sheu B.-S.; Chang W.-K.; Huang W.-C.; Yang C.-L.; Chang Y.-F.; Wang T.-E.; Chen Y.-J.; Wu I.-C.; Chen M.-J. |
| 臺大學術典藏 |
2020-11-02T02:04:19Z |
14 Day sequential therapy versus 10 day bismuth quadruple therapy containing high-dose esomeprazole in the first-line and second-line treatment of Helicobacter pylori: A multicentre, non-inferiority, randomized trial
|
Liou J.-M.; Chen C.-C.; Fang Y.-J.; Chen P.-Y.; Chang C.-Y.; Chou C.-K.; Chen M.-J.; Tseng C.-H.; Lee J.-Y.; Yang T.-H.; Chiu M.-C.; Yu J.-J.; Kuo C.-C.; Luo J.-C.; Hsu W.-F.; Helicobacter Consortium; Taiwan Gastrointestinal Disease; MING-SHIANG WU; Bair M.-J.; Lee Y.-C.; Hu W.-H.; Tsai M.-H.; Lin J.-T.; Shun C.-T.; Twu G. |
| 臺大學術典藏 |
2020-11-02T02:04:18Z |
Prior gastroscopy and mortality in patients with gastric cancer: a matched retrospective cohort study
|
Leung W.K.; Ho H.J.; Lin J.-T.; MING-SHIANG WU; Wu C.-Y. |
| 臺大學術典藏 |
2020-11-02T02:04:18Z |
First-line Helicobacter pylori eradication therapies in countries with high and low clarithromycin resistance: A systematic review and network meta-analysis
|
Wu C.-Y.; Liou J.-M.; MING-SHIANG WU; Lin J.-T.; Zou B.; Ho H.J.; Shiu S.-I.; Yeo Y.H. |
| 臺大學術典藏 |
2020-11-02T02:04:16Z |
Temporal trend and risk determinants of hepatocellular carcinoma in chronic hepatitis B patients on entecavir or tenofovir
|
Hsu Y.-C.; Ho H.-J.; Lee T.-Y.; Huang Y.-T.; MING-SHIANG WU; Lin J.-T.; Wu C.-Y.; El-Serag H.B. |
Showing items 1906-1955 of 2489 (50 Page(s) Totally)
<< < 34 35 36 37 38 39 40 41 42 43 > >>
View [10|25|50] records per page
